Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Widimsky

Showing results (61-70 of 232) with videos related to

Pageof 24
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 5, 2021
Endovascular thrombectomy 2020: open issuesPeter Lanzer, Petr Widimsky, Diana A Gorog, et al.
Current Medical Research and Opinion|July 16, 2014
An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrelRobert Wilcox, Kamran Iqbal, Tim Costigan, et al.
Heart and Vessels|May 20, 2018
Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trialMarco Loffi, Petr Tousek, Tomas Budesinsky, et al.
The American Journal of Cardiology|December 14, 2011
Renal function assessed using cystatin C and antiplatelet efficacy of clopidogrel assessed using the vasodilator-stimulated phosphoprotein index in patients having percutaneous coronary interventionZuzana Motovska, Denisa Odvodyova, Michaela Fischerova, et al.
International Journal of Cardiology|April 17, 2015
Potential role of invariant natural killer T cells in outcomes of acute myocardial infarctionJan Novak, Jan Dobrovolny, Petr Tousek, et al.
International Journal of Cardiology|February 24, 2009
Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectivenessZuzana Motovska, Petr Widimsky, Robert Petr, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 29, 2008
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET)Frantisek Bednar, Pavel Osmancik, Tomas Vanek, et al.
Kardiologia Polska|March 1, 2019
Electrocardiogram changes due to myocardial infarction in a patient with selective His bundle pacingKarol Curila, Petr Stros, Dalibor Herman, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 8, 2016
Off-pump versus on-pump coronary artery bypass grafting surgery in high-risk patients: PRAGUE-6 trial at 30 days and 1 yearJan Hlavicka, Zbynek Straka, Stepan Jelinek, et al.
Journal of Cardiovascular Pharmacology|February 28, 2009
Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox"Zuzana Motovska, Petr Widimsky, Robert Petr, et al.
Pageof 24

Showing results (61-70 of 232) with videos related to

Sort By:
Pageof 24
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 5, 2021
Endovascular thrombectomy 2020: open issuesPeter Lanzer, Petr Widimsky, Diana A Gorog, et al.
Current Medical Research and Opinion|July 16, 2014
An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrelRobert Wilcox, Kamran Iqbal, Tim Costigan, et al.
Heart and Vessels|May 20, 2018
Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trialMarco Loffi, Petr Tousek, Tomas Budesinsky, et al.
The American Journal of Cardiology|December 14, 2011
Renal function assessed using cystatin C and antiplatelet efficacy of clopidogrel assessed using the vasodilator-stimulated phosphoprotein index in patients having percutaneous coronary interventionZuzana Motovska, Denisa Odvodyova, Michaela Fischerova, et al.
International Journal of Cardiology|April 17, 2015
Potential role of invariant natural killer T cells in outcomes of acute myocardial infarctionJan Novak, Jan Dobrovolny, Petr Tousek, et al.
International Journal of Cardiology|February 24, 2009
Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectivenessZuzana Motovska, Petr Widimsky, Robert Petr, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 29, 2008
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET)Frantisek Bednar, Pavel Osmancik, Tomas Vanek, et al.
Kardiologia Polska|March 1, 2019
Electrocardiogram changes due to myocardial infarction in a patient with selective His bundle pacingKarol Curila, Petr Stros, Dalibor Herman, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 8, 2016
Off-pump versus on-pump coronary artery bypass grafting surgery in high-risk patients: PRAGUE-6 trial at 30 days and 1 yearJan Hlavicka, Zbynek Straka, Stepan Jelinek, et al.
Journal of Cardiovascular Pharmacology|February 28, 2009
Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox"Zuzana Motovska, Petr Widimsky, Robert Petr, et al.
Pageof 24